A webinar with the presenter doing a live presentation via zoom. The presenter is one of the officers in our Malaysian Regulatory Authority.
GMP inspections are typically conducted on-site for pharmaceutical manufacturers,. The outbreak of COVID-19 pandemic has brought about different approaches including off-site .audits.
Learn from Senior Officers of the Malaysian National Pharmaceutical Regulatory Agency (NPRA) on what is expected from regulators during a Remote Audit and Desktop Assessment From this webinar participants will gain an understanding of the following: